Potential Parkinson’s Treatment, CDNF, Shows Safety and Tolerability at One Year

[JayPwP]

A potential Parkinson’s treatment called cerebral dopamine neurotrophic factor (CDNF) continues to be safe and well tolerated by patients with moderate disease using it for up to one year in a Phase 1/2 trial, and shows a promising potential to ease motor symptoms and slow disease progression, Herantis Pharma, its developer, reported

parkinsonsnewstoday.com/202...

[jeffreyn]

Probably the biggest downside is that it requires brain surgery.

[JayPwP in reply to jeffreyn]

So did GDNF

[jeffreyn in reply to JayPwP]

Exactly!

[JayPwP in reply to jeffreyn]

But the delivery port is temporary. Look at the videos in my reply on GDNF here:

healthunlocked.com/parkinso...

[jeffreyn in reply to JayPwP]

Temporary for a clinical trial maybe, but surely not temporary for treatment (i.e. "one and done")?

[JayPwP in reply to jeffreyn]

The GDNF trial used the ports for 3 months I think, but you might be correct

[Canddy in reply to jeffreyn]

agree

[Hidden]

Have you heard about fast w

[JayPwP in reply to Hidden]

Fast walking?

[WinnieThePoo in reply to JayPwP]

Less intrusive..

[JayPwP in reply to WinnieThePoo]

As per John Pepper theory, fast walking boosts GDNF, a natural brain protein.

This is CDNF, this is different than GDNF

[WinnieThePoo in reply to JayPwP]

We were kidding

[JayPwP in reply to WinnieThePoo]

Oops! Sorry

[Hidden in reply to WinnieThePoo]

Reverses essential tremor

[Hikoi in reply to Hidden]

I wonder what it reverses as Mr P was able to exercise intensively for 90 mins a day but apparently it didnt help.. only walking fast and an antidepressant did. He never stopped moving and didnt need to learn how to walk again, I believe a certain author manipulated his story to fit the author’s thesis.